Home / Cefepime / United States
US ATC J01DE01 · updated 2 Nov 2026
Cefepime shortage in United States
Is there a Cefepime shortage in United States?
Yes. As of 2 Nov 2026, 2 Cefepime products are reported short in United States, the first since 10 Feb 2026. No return date has been given. Main reason: not stated.
Also short in Canada. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Cefepime Hydrochloride, Injection, 1 g (NDC 63323-326-20) discontinuation | Fresenius Kabi USA, LLC | 10 Feb 2026 | not given | Not stated |
| US | Cefepime Hydrochloride, Injection, 2 g (NDC 63323-340-20) discontinuation | Fresenius Kabi USA, LLC | 10 Feb 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).